These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 8392095

  • 1. Alloreactive cytotoxic T lymphocytes generated in the presence of viral-derived peptides show exquisite peptide and MHC specificity.
    Alexander-Miller MA, Burke K, Koszinowski UH, Hansen TH, Connolly JM.
    J Immunol; 1993 Jul 01; 151(1):1-10. PubMed ID: 8392095
    [Abstract] [Full Text] [Related]

  • 2. Peptides control the gain and loss of allele specificity by mutated MHC class I molecules.
    Hengel H, Burke K, Kyburz D, Zinkernagel RM, Koszinowski UH.
    J Immunol; 1995 May 01; 154(9):4557-64. PubMed ID: 7722309
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Alloreactive and syngeneic CTL are comparably dependent on interaction with MHC class I alpha-helical residues.
    Hornell TM, Solheim JC, Myers NB, Gillanders WE, Balendiran GK, Hansen TH, Connolly JM.
    J Immunol; 1999 Sep 15; 163(6):3217-25. PubMed ID: 10477590
    [Abstract] [Full Text] [Related]

  • 5. The Q7 alpha 3 domain alters T cell recognition of class I antigens.
    Aldrich CJ, Lowen LC, Mann D, Nishimura M, Hood L, Stroynowski I, Forman J.
    J Immunol; 1991 May 01; 146(9):3082-90. PubMed ID: 1849941
    [Abstract] [Full Text] [Related]

  • 6. Different types of allospecific CTL clones identified by their ability to recognize peptide loading-defective target cells.
    Aosai F, Ohlen C, Ljunggren HG, Höglund P, Franksson L, Ploegh H, Townsend A, Kärre K, Stauss HJ.
    Eur J Immunol; 1991 Nov 01; 21(11):2767-74. PubMed ID: 1936122
    [Abstract] [Full Text] [Related]

  • 7. Role of endogenous peptides in murine allogenic cytotoxic T cell responses assessed using transfectants of the antigen-processing mutant 174xCEM.T2.
    Crumpacker DB, Alexander J, Cresswell P, Engelhard VH.
    J Immunol; 1992 May 15; 148(10):3004-11. PubMed ID: 1374446
    [Abstract] [Full Text] [Related]

  • 8. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
    von Herrath MG, Coon B, Lewicki H, Mazarguil H, Gairin JE, Oldstone MB.
    J Immunol; 1998 Nov 01; 161(9):5087-96. PubMed ID: 9794447
    [Abstract] [Full Text] [Related]

  • 9. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.
    Shirai M, Pendleton CD, Berzofsky JA.
    J Immunol; 1992 Mar 15; 148(6):1657-67. PubMed ID: 1371784
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants.
    Byrne JA, Ahmed R, Oldstone MB.
    J Immunol; 1984 Jul 15; 133(1):433-9. PubMed ID: 6202788
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Predominant utilization of V beta 8+ T cell receptor genes in the H-2Ld-restricted cytotoxic T cell response against the immediate-early protein pp89 of the murine cytomegalovirus.
    Rodewald HR, Koszinowski UH, Eichmann K, Melchers I.
    J Immunol; 1989 Dec 15; 143(12):4238-43. PubMed ID: 2556481
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.